FOXA2 and Parkinson disease: Moreover, we examined the expression of FoxA2 in brain tissue sections and observed a significant increase in FoxA2 expression in the high-dose drug and low-dose drug groups compared with the PD model group (Figures 4(e) and 4(f)).